(DARE) Dare Bioscience - Performance -36.9% in 12m

DARE performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.

Performance Rating -84.43%
#31 in Peer-Group
Rel. Strength 14.88%
#6322 in Stock-Universe
Total Return 12m -36.94%
#27 in Peer-Group
Total Return 5y -79.89%
#29 in Peer-Group
P/E Value
P/E Trailing -
P/E Forward -
High / Low USD
52 Week High 4.41 USD
52 Week Low 2.37 USD
Sentiment Value
VRO Trend Strength +-100 9.09
Buy/Sell Signal +-5 -2.38
Support / Resistance Levels
Support
Resistance
12m Total Return: DARE (-36.9%) vs XLV (-5.4%)
Total Return of Dare Bioscience versus its related sector ETF XLV
5y Drawdown (Underwater) Chart
5 Year Drawdown / Underwater Chart for (DARE) Dare Bioscience - Performance -36.9% in 12m

Top Performer in Health Care Supplies

Short Term Performance

Symbol 1w 1m 3m
DARE -6.64% -21.1% -17.3%
TELA 12.1% 36.6% 59.0%
VNRX -11.6% 44.0% 33.3%
XTNT 25.3% 11.8% 57.2%

Long Term Performance

Symbol 6m 12m 5y
DARE -23.4% -36.9% -79.9%
XTNT 68.0% 15.3% -23.8%
SIBN 34.2% 45.9% 16.8%
VNRX 26.7% 22.6% -79.7%

Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating

Symbol 1m 12m 5y P/E P/E Forward PEG EPS Stability EPS CAGR
LNTH NASDAQ
Lantheus Holdings
6.13% 2.32% 462% 23 11.8 0.61 60.0% 46.6%
COO NASDAQ
The Cooper Companies
6.21% -17.6% -1.81% 34.3 17.1 1.15 -82.9% -27.2%
HAE NYSE
Haemonetics
8.46% -9.82% -19.4% 21.2 14.5 1.21 71.2% 96.8%
ALGN NASDAQ
Align Technology
6.06% -20.7% -32.4% 31.9 17.6 0.97 -33.8% -15.7%

Performance Comparison: DARE vs XLV vs S&P 500

XLV (Health Care Sector SPDR ETF) is the Sector Benchmark for DARE
Total Return (including Dividends) DARE XLV S&P 500
1 Month -21.12% 2.04% 4.55%
3 Months -17.30% -7.24% 10.78%
12 Months -36.94% -5.41% 14.71%
5 Years -79.89% 43.58% 112.53%

Trend Score (consistency of price movement) DARE XLV S&P 500
1 Month -78.6% 34.5% 79.2%
3 Months -12.3% -46.5% 92.9%
12 Months -78.7% -71.8% 44.2%
5 Years -87.2% 87.9% 84%

Relative Strength (compared with Indexes) Rank in Peer Group vs. XLV vs. S&P 500
1 Month %th11.76 -22.70% -24.56%
3 Month %th17.65 -10.84% -25.35%
12 Month %th23.53 -33.33% -45.03%
5 Years %th17.65 -85.99% -90.54%

FAQs

Does Dare Bioscience (DARE) outperform the market?

No, over the last 12 months DARE made -36.94%, while its related Sector, the Health Care Sector SPDR (XLV) made -5.41%. Over the last 3 months DARE made -17.30%, while XLV made -7.24%.

Performance Comparison DARE vs Indeces and Sectors

Above 0 means better perfomance compared to Symbol in this Timeframe

DARE vs. Indices

Symbol 1w 1m 6m 12m
US S&P 500 SPY -9.6% -25.7% -29.5% -52%
US NASDAQ 100 QQQ -10.4% -26.7% -31.6% -52%
German DAX 40 DAX -9.4% -21.1% -42.4% -67%
Shanghai Shenzhen CSI 300 CSI 300 -9.3% -25.3% -27.4% -55%
Hongkong Hang Seng HSI -9.2% -26.9% -45.2% -72%
India NIFTY 50 INDA -9.2% -23.2% -29.2% -37%
Brasil Bovespa EWZ -10.9% -28.9% -54% -50%

DARE vs. Sectors

Symbol 1w 1m 6m 12m
Communication Services XLC -11.1% -27.9% -36.1% -66%
Consumer Discretionary XLY -8% -22.8% -20.7% -57%
Consumer Staples XLP -6.1% -19.5% -27.7% -46%
Energy XLE -5.2% -24.6% -24% -33%
Financial XLF -9.7% -24.2% -32.5% -66%
Health Care XLV -8.6% -23.2% -22.2% -32%
Industrial XLI -9.2% -24.9% -36.1% -61%
Materials XLB -7.6% -22.7% -28.8% -40%
Real Estate XLRE -5.1% -21.1% -26.8% -49%
Technology XLK -10.9% -30% -32.7% -49%
Utilities XLU -7.2% -21.2% -32.8% -61%
Aerospace & Defense XAR -11.5% -31% -50.8% -90%
Biotech XBI -7.4% -23.2% -15.5% -26%
Homebuilder XHB -7.8% -27.2% -18.2% -38%
Retail XRT -6.5% -22.5% -20.7% -43%

DARE vs. Commodities

Symbol 1w 1m 6m 12m
Oil USO -2.3% -26.2% -20.2% -27%
Natural Gas UNG 2.6% -11.7% -14.3% -29%
Gold GLD -4.6% -18.9% -49.3% -78%
Silver SLV -6.2% -25% -48% -59%
Copper CPER -9.9% -25.3% -49.2% -52%

DARE vs. Bonds

Symbol 1w 1m 6m 12m
iShares 20+ Years Bond TLT -8.4% -24.8% -26.3% -39%
iShares High Yield Corp. Bond HYG -7.5% -23% -28.4% -48%